
|
|
|
National & World Ag News Headlines |
 |
Monsanto to Re-enter the Wheat Seed Business
USAgNet - 07/15/2009
Monsanto Company announced it is expanding its strong seeds and traits portfolio to include wheat. The company has acquired the assets of WestBred, LLC, a Montana-based company that specializes in
wheat germplasm, the crop's seed genetic material. The investment will bolster the future growth of Monsanto's seeds and traits platform and allow farmers to benefit from the company's experience in
drought-, disease- and pest-tolerance innovations.
"The U.S. wheat industry has come together to call for new technology investment, and we believe we have game-changing technologies - like our drought-tolerance and improved-yield traits - that can
meaningfully address major challenges wheat growers face every season," said Carl Casale, executive vice president of global strategy and operations for Monsanto. "Through WestBred, we'll be able to
deliver advances in breeding and biotechnology to deliver a step-change in yield while creating a springboard for new partnerships and collaboration opportunities that create additional value for farmers."
WestBred, owned indirectly by Barkley Seed, Inc., is a premier private wheat germplasm company in the United States, with germplasm assets in all classes of wheat. WestBred's existing breeding
capabilities and commercial operations will become the centerpiece of Monsanto's wheat platform. In addition, Monsanto will seek public and private partnerships that can help deliver on the promise of
technology improvements in wheat for farmers.
"This is a tremendous opportunity for the grain industry," said Robby Barkley, president and CEO, Barkley Seed, Inc. "The combined resources of Monsanto and WestBred will support the development of
new technology and traits that can benefit many."
"As WestBred looked at the wheat industry, we saw a need for technology infusion to be competitive with other crops farmers are growing," said Ron Ueland, president of WestBred. "We believe that linking
up with a company like Monsanto with a proven track record as an innovator is the best route to accelerate the development of new technologies."
Because the $45 million acquisition represents a long-term investment in research and development and breeding, the company does not expect the acquisition to be accretive to earnings until the middle to
latter part of the next decade.
|
|


|
 |
|
Copyright © 2010 - USAgNet.com. All Rights Reserved. |
 |
|